Summary
Justin Feigelman is a Director of Clinical Pharmacology with 11 years of experience translating quantitative modeling and statistical inference into drug development decisions across Genentech, Regeneron, and Gilead. Trained as a PhD mathematician with postdoctoral work in single-cell computational biology at ETH Zurich, he blends deep stochastic modeling and parameter inference expertise with practical QSP and simulation work for clinical trial design. He has a track record of building models that connect single-cell dynamics and transcriptomics to population-level pharmacology, and he frequently bridges biology, software development, and ML-driven analysis to inform program strategy. Based in the San Francisco Bay Area, he brings uncommon dual fluency in rigorous mathematical theory and hands-on pharmacology execution.
11 years of coding experience
8 years of employment as a software developer
The University of Arizona
Bachelor's degree Physics, Bachelor's degree Physics at University of California, Berkeley
Doctor of Philosophy (PhD) Mathematics, Doctor of Philosophy (PhD) Mathematics at Technical University of Munich
MS Computational Biology and Bioinformatics, MS Computational Biology and Bioinformatics at ETH Zürich
German, English